Meine Merkliste
my.bionity.com  
Login  

1.439 Aktuelle Fachpublikationen in Oncogene

rss
mit folgenden Suchkriterien:

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1|[sol]|Akt|[sol]|NF-|[kappa]|B signaling

11.04.2016 | J Li; H Wu; W Li; L Yin; S Guo; X Xu; Y Ouyang; Z Zhao; S Liu; Y Tian; Z Tian; J Ju; B Ni; H Wang, Oncogene, 2016

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling Oncogene advance online publication, April 11 2016. doi:10.1038/onc.2016.90 Authors: J Li, H Wu, W Li, L Yin, S Guo, X Xu, Y Ouyang, Z Zhao, S Liu, Y Tian, Z ...

mehr

PML is required for telomere stability in non-neoplastic human cells

07.04.2016 | M Marchesini; R Matocci; L Tasselli; V Cambiaghi; A Orleth; L Furia; C Marinelli; S Lombardi; G Sammarelli; F Aversa ..., Oncogene, 2016

PML is required for telomere stability in non-neoplastic human cells Oncogene 35, 1876 (07 April 2016). doi:10.1038/onc.2015.312 Authors: M Marchesini, R Matocci, L Tasselli, V Cambiaghi, A Orleth, L Furia, C Marinelli, S Lombardi, G Sammarelli, F Aversa, S Minucci, M ...

mehr

CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor

04.04.2016 | S Nodomi; K Umeda; S Saida; T Kinehara; T Hamabata; T Daifu; I Kato; H Hiramatsu; K-i Watanabe; Y Kuwahara; T Iehara ..., Oncogene, 2016

CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor Oncogene advance online publication, April 4 2016. doi:10.1038/onc.2016.72 Authors: S Nodomi, K Umeda, S Saida, T Kinehara, T Hamabata, T Daifu, I Kato, H Hiramatsu, ...

mehr

SHP-2-upregulated ZEB1 is important for PDGFR|[alpha]|-driven glioma epithelial|[ndash]|mesenchymal transition and invasion in mice and humans

04.04.2016 | L Zhang; W Zhang; Y Li; A Alvarez; Z Li; Y Wang; L Song; D Lv; I Nakano; B Hu; S-Y Cheng; H Feng, Oncogene, 2016

SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans Oncogene advance online publication, April 4 2016. doi:10.1038/onc.2016.100 Authors: L Zhang, W Zhang, Y Li, A Alvarez, Z Li, Y Wang, L Song, D Lv, I ...

mehr

Aberrant activation of the PI3K|[sol]|mTOR pathway promotes resistance to sorafenib in AML

21.03.2016 | O Lindblad; E Cordero; A Puissant; L Macaulay; A Ramos; N N Kabir; J Sun; J Vallon-Christersson; K Haraldsson; M T H ..., Oncogene, 2016

Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML Oncogene advance online publication, March 21 2016. doi:10.1038/onc.2016.41 Authors: O Lindblad, E Cordero, A Puissant, L Macaulay, A Ramos, N N Kabir, J Sun, J Vallon-Christersson, K Haraldsson, M ...

mehr

Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells

14.03.2016 | H Jin; K Lee; Y-H Kim; H K Oh; Y-I Maeng; T-H Kim; D-S Suh; J Bae, Oncogene, 2016

Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells Oncogene advance online publication, March 14 2016. doi:10.1038/onc.2016.54 Authors: H Jin, K Lee, Y-H Kim, H K Oh, Y-I Maeng, T-H Kim, D-S Suh & J Bae

mehr

Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin|[sol]||[plus]| mice

14.03.2016 | W Liu; H Li; S-H Hong; G P Piszczek; W Chen; G P Rodgers, Oncogene, 2016

Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice Oncogene advance online publication, March 14 2016. doi:10.1038/onc.2016.58 Authors: W Liu, H Li, S-H Hong, G P Piszczek, W Chen & G P Rodgers

mehr

Topoisomerase II|[alpha]| mediates TCF-dependent epithelial|[ndash]|mesenchymal transition in colon cancer

07.03.2016 | Q Zhou; A D Abraham; L Li; A Babalmorad; S Bagby; J J Arcaroli; R J Hansen; F A Valeriote; D L Gustafson; J Schaack; ..., Oncogene, 2016

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer Oncogene advance online publication, March 7 2016. doi:10.1038/onc.2016.29 Authors: Q Zhou, A D Abraham, L Li, A Babalmorad, S Bagby, J J Arcaroli, R J Hansen, F A Valeriote, D L Gustafson, J ...

mehr

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

03.03.2016 | M M Morrison; M M Williams; D B Vaught; D Hicks; J Lim; C McKernan; L Aurisicchio; G Ciliberto; C Simion; C Sweeney; ..., Oncogene, 2016

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth Oncogene 35, 1206 (03 March 2016). doi:10.1038/onc.2015.418 Authors: M M Morrison, M M Williams, D B Vaught, D Hicks, J Lim, C McKernan, L Aurisicchio, G ...

mehr

RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma

29.02.2016 | T Sakurai; K Isogaya; S Sakai; M Morikawa; Y Morishita; S Ehata; K Miyazono; D Koinuma, Oncogene, 2016

RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma Oncogene advance online publication, February 29 2016. doi:10.1038/onc.2016.35 Authors: T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono & D Koinuma

mehr

Seite 1 von 144
Suche per e-Mail abonnieren

Sie erhalten passend zu Ihrer Suche die neusten Suchergebnisse per E-Mail. Dieser Service ist für Sie kostenlos und kann jederzeit abbestellt werden.

Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.